Drug Shortage Report for CEFTRIAXONE FOR INJECTION

Last updated on 2018-05-24 History
Report ID 15628
Drug Identification Number 02409968
Brand name CEFTRIAXONE FOR INJECTION
Common or Proper name Ceftriaxone for Injection 100g SmartPak
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 100g SmartPak
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-11
Estimated end date 2018-05-18
Actual end date 2018-05-23
Shortage status Resolved
Updated date 2018-05-24
Company comments Shortage Resolved.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2018-05-24 English Compare
v16 2018-05-23 French Compare
v15 2018-05-23 English Compare
v14 2018-04-19 French Compare
v13 2018-04-19 English Compare
v12 2018-01-26 French Compare
v11 2018-01-26 English Compare
v10 2017-12-12 English Compare
v9 2017-12-08 French Compare
v8 2017-12-08 English Compare
v7 2017-12-08 French Compare
v6 2017-12-08 English Compare
v5 2017-11-13 French Compare
v4 2017-11-13 English Compare
v3 2017-07-13 English Compare
v2 2017-07-12 French Compare
v1 2017-07-12 English Compare

Showing 1 to 17 of 17